March 15, 2016
Start date & time in your local time zone.
Zusammenfassung der Präsentationen
Präsentationen
Die folgenden Präsentationen wurden auf dem Treffen 2016 gehalten. Besuchen Sie den ECD Global Alliance YouTube-Kanal für alle veröffentlichten Videos zu ECD.
Presenter Presentation Slides Videos
Corrado Campochiaro, MD Management of ECD Symptoms and Side Effects of Treatments Management of ECD Symptoms and Side Effects of Treatments
Giulio Cavalli, MD Adult Onset (Infratentorial) Leukoencephalopathy as Presenting Manifestation of Erdheim-Chester Disease Adult Onset (Infratentorial) Leukoencephalopathy as Presenting Manifestation of Erdheim-Chester Disease
Carine Courtillot, MD Endocrine manifestations in Erdheim-Chester disease Endocrine manifestations in Erdheim-Chester disease
Benjamin Durham, MD Insights into the Cell-of-Origin of the Histiocytoses Using Patient-Derived Xenograft Murine Models Insights into the Cell-of-Origin of the Histiocytoses Using Patient-Derived Xenograft Murine Models
Marina Ferrarini, MD Tailoring Treatment for Erdheim-Chester Disease: Focus on ECD Tailoring Treatment for Erdheim-Chester Disease: Focus on ECD
Ronald Go, MD Efficacy of Cladribine (2-CdA) in the Treatment of Erdheim-Chester Disease (ECD) Efficacy of Cladribine (2-CdA) in the Treatment of Erdheim-Chester Disease (ECD)
Filip Janku, MD, PhD Encouraging activity of MEK inhibitor trametinib in patients with Erdheim-Chester disease irrespective of BRAF mutation statusClinical Molecular Profiling to Detect Targetable Alterations in Archival Tumor Tissue and Cell-free DNA from Patients with Erdheim-Chester Disease Encouraging activity of MEK inhibitor trametinib in patients with Erdheim-Chester disease irrespective of BRAF mutation statusClinical Molecular Profiling to Detect Targetable Alterations in Archival Tumor Tissue and Cell-free DNA from Patients with Erdheim-Chester Disease
Javier Martin, MD, PhD Future Genetic Studies in Erdheim-Chester disease – GWAS Study Future Genetic Studies in Erdheim-Chester disease – GWAS Study
Kenneth McClain, MD, PhD Elevated CSF Osteopontin and Circulating Cells with BRAF Mutations in Patients with Langerhans Cell Histiocytosis-Associated Neurodegeneration -A Model for ECD? Elevated CSF Osteopontin and Circulating Cells with BRAF Mutations in Patients with Langerhans Cell Histiocytosis-Associated Neurodegeneration -A Model for ECD?
Augusto Vaglio, MD, PhD MRI evidence of cardiac involvement in Erdheim-Chester disease MRI evidence of cardiac involvement in Erdheim-Chester disease
Subscribe to calendar
Standort: Paris, Frankreich
